Clearside Biomedical Share Price (NASDAQ: CLSD)

$0.41

▲

0.01

(2.5%)

Live

Last updated on August 28, 2025 at 12:35 am IST

$₹

Check the interactive Clearside Biomedical Stock chart to analyse performance

Clearside Biomedical stock performance

as on August 28, 2025 at 12:35 am IST

Today's Low:$0.40
Today's High:$0.41
$0.41
2.44%
Downside
Day's Volatility :2.44%
Upside
0.0%
52 Weeks Low:$0.29
52 Weeks High:$1.65
$0.41
28.78%
Downside
52 Weeks Volatility :82.3%
Upside
75.15%

Clearside Biomedical Stock Returns

Period	Clearside Biomedical Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-50.14%	3.7%	0.0%
6 Months	-56.42%	-6.9%	0.0%
1 Year	-61.17%	-11.9%	0.0%
3 Years	-70.95%	7.7%	-6.9%

Clearside Biomedical Inc Key Stats

Check Clearside Biomedical key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$0.4
Open	$0.404
Today's High	$0.4048
Today's Low	$0.384
Market Capitalization	$31.6M
Today's Volume	$369.6K
52 Week High	$1.65
52 Week Low	$0.292
Revenue TTM	$4.2M
EBITDA	$-21.5M
Earnings Per Share (EPS)	$-0.36
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-1310.02%

Stock Returns calculator for Clearside Biomedical Stock including INR - Dollar returns

The Clearside Biomedical stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Clearside Biomedical investment value today

Current value as on today

₹45,267

Returns

₹54,733

(-54.73%)

Returns from Clearside Biomedical Stock

₹59,406 (-59.41%)

Dollar Returns*

₹4,673 (+4.67%)

Indian investors sentiment towards Clearside Biomedical Stock

-69.3%

Period: Jul 27, 2025 to Aug 26, 2025. Change in 30 Days versus previous period

Investment in Clearside Biomedical Shares from India has dropped by -69.3% over the past 30 days, indicating reduced transactional activity.

-63%

Period: Jul 27, 2025 to Aug 26, 2025. Change in 30 Days versus previous period

Search interest for Clearside Biomedical Stock from India on INDmoney has decreased by -63% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Clearside Biomedical Inc

Name
Holdings %
Name
Holdings %
Vanguard Group Inc
4.28%
Carmignac Gestion
1.92%
BlackRock Inc
1.02%
Geode Capital Management, LLC
1.01%
Renaissance Technologies Corp
0.71%
First Manhattan Co. LLC
0.44%

Analyst Recommendation on Clearside Biomedical Stock

Rating

Trend

Buy

91%Buy

8%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Clearside Biomedical(by analysts ranked 0 to 5 stars)

Clearside Biomedical Share Price Target

What analysts predicted

Upside of 875.61%

Target:

$4.00

Current:

$0.41

Clearside Biomedical share price target is $4.00, a slight Upside of 875.61% compared to current price of $0.41 as per analysts' prediction.

Clearside Biomedical Stock Insights

Price Movement
In the last 7 days, CLSD stock has moved down by -3.8%
Decreasing Revenue
Revenue is down for the last 2 quarters, 2.33M → 492.0K (in $), with an average decrease of 78.9% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -8.22M → -4.49M (in $), with an average increase of 82.9% per quarter
CLSD vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.0% return, outperforming this stock by 122.2%
CLSD vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 113.9% return, outperforming this stock by 185.7%
Price to Sales
ForCLSD every $1 of sales, investors are willing to pay $7.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.7 for every $1 of sales.

Clearside Biomedical Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$2.2M	↑ 7143.33%
Net Income	$-30.6M	↓ 63.1%
Net Profit Margin	-1.4K%	↑ 274653.7%

	FY20	Y/Y Change
Revenue	$7.9M	↑ 263.28%
Net Income	$-18.0M	↓ 41.0%
Net Profit Margin	-228.4%	↑ 1177.9%

	FY21	Y/Y Change
Revenue	$29.6M	↑ 274.65%
Net Income	$376.0K	↓ 102.09%
Net Profit Margin	1.27%	↑ 229.67%

	FY22	Y/Y Change
Revenue	$1.3M	↓ 95.51%
Net Income	$-32.9M	↓ 8862.5%
Net Profit Margin	-2.5K%	↓ 2484.09%

	FY23	Y/Y Change
Revenue	$8.2M	↑ 519.89%
Net Income	$-32.5M	↓ 1.4%
Net Profit Margin	-394.91%	↑ 2087.91%

	FY24	Y/Y Change
Revenue	$1.7M	↓ 79.77%
Net Income	$-34.4M	↑ 5.75%
Net Profit Margin	-2.1K%	↓ 1669.51%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$230.0K	↓ 96.38%
Net Income	$-11.8M	↑ 143.44%
Net Profit Margin	-5.1K%	↓ 5038.2%

	Q2 FY24	Q/Q Change
Revenue	$90.0K	↓ 60.87%
Net Income	$-7.6M	↓ 35.44%
Net Profit Margin	-8.4K%	↓ 3323.43%

	Q3 FY24	Q/Q Change
Revenue	$1.0M	↑ 1053.33%
Net Income	$-7.7M	↑ 1.24%
Net Profit Margin	-740.66%	↑ 7697.12%

	Q4 FY24	Q/Q Change
Revenue	$306.0K	↓ 70.52%
Net Income	$-7.3M	↓ 4.97%
Net Profit Margin	-2.4K%	↓ 1646.92%

	Q1 FY25	Q/Q Change
Revenue	$2.3M	↑ 661.44%
Net Income	$-8.2M	↑ 12.55%
Net Profit Margin	-352.92%	↑ 2034.66%

	Q2 FY25	Q/Q Change
Revenue	$492.0K	↓ 78.88%
Net Income	$-4.5M	↓ 45.34%
Net Profit Margin	-913.62%	↓ 560.7%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$2.2M	↑ 7143.33%

	FY20	Y/Y Change
Profit	$7.9M	↑ 263.28%

	FY21	Y/Y Change
Profit	$29.6M	↑ 274.65%

	FY22	Y/Y Change
Profit	$1.1M	↓ 96.2%

	FY23	Y/Y Change
Profit	$7.9M	↑ 600.89%

	FY24	Y/Y Change
Profit	$1.5M	↓ 80.75%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$202.0K	↓ 96.81%

	Q2 FY24	Q/Q Change
Profit	$90.0K	↓ 55.45%

	Q3 FY24	Q/Q Change
Profit	$1.0M	↑ 1053.33%

	Q4 FY24	Q/Q Change
Profit	$157.0K	↓ 84.87%

	Q1 FY25	Q/Q Change
Profit	$2.1M	↑ 1226.11%

	Q2 FY25	Q/Q Change
Profit	$408.0K	↓ 80.4%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$-27.1M	↓ 65.82%
Investing Cash Flow	$32.9M	↓ 975.66%
Financing Cash Flow	$8.7M	↓ 89.37%

	FY20	Y/Y Change
Operating Cash Flow	$-13.1M	↓ 51.53%
Investing Cash Flow	$-55.0K	↓ 100.17%
Financing Cash Flow	$7.9M	↓ 9.52%

	FY21	Y/Y Change
Operating Cash Flow	$-10.7M	↓ 18.19%
Investing Cash Flow	$-246.0K	↑ 347.27%
Financing Cash Flow	$23.8M	↑ 202.3%

	FY22	Y/Y Change
Operating Cash Flow	$-13.4M	↑ 24.52%
Investing Cash Flow	$-246.0K	↑ 0.0%
Financing Cash Flow	$31.3M	↑ 31.75%

	FY23	Y/Y Change
Operating Cash Flow	$-18.1M	↑ 35.69%
Investing Cash Flow	$-1.8M	↑ 622.36%
Financing Cash Flow	$414.0K	↓ 98.68%

	FY24	Y/Y Change
Operating Cash Flow	$-24.7M	↑ 36.19%
Investing Cash Flow	$-638.0K	↓ 64.1%
Financing Cash Flow	$16.4M	↑ 3870.05%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-7.9M	↓ 1686.06%
Investing Cash Flow	$-57.0K	↓ 52.5%
Financing Cash Flow	$14.3M	↓ 5680.93%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$-5.7M	↓ 27.65%
Investing Cash Flow	$-11.4M	↑ 19964.91%
Financing Cash Flow	$0.0	↓ 100.0%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-5.9M	↑ 4.1%
Investing Cash Flow	$1.5M	↓ 113.54%
Financing Cash Flow	$14.0K	-

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-5.3M	↓ 11.14%
Investing Cash Flow	$9.3M	↑ 500.84%
Financing Cash Flow	$2.1M	↑ 14750.0%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$-5.8M	↑ 10.96%
Investing Cash Flow	$-9.0K	↓ 100.1%
Financing Cash Flow	$-553.0K	↓ 126.6%

Clearside Biomedical Technicals Summary

Sell

Neutral

Buy

Clearside Biomedical is currently in a neutral trading position according to technical analysis indicators.

Clearside Biomedical Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Clearside Biomedical Inc	-11.88%	-56.42%	-61.17%	-70.95%	-92.88%
Regeneron Pharmaceuticals, Inc.	5.16%	-16.9%	-51.12%	-0.89%	-2.51%
Beone Medicines Ltd	4.54%	18.87%	52.28%	84.02%	26.72%
Vertex Pharmaceuticals Incorporated	-16.02%	-19.22%	-19.42%	37.43%	43.36%
Alnylam Pharmaceuticals, Inc.	38.9%	84.99%	60.96%	115.82%	243.29%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Clearside Biomedical Inc	133.0	NA	0.0	-0.3	-13.1	-0.55	NA	-0.62
Regeneron Pharmaceuticals, Inc.	14.86	14.86	1.21	39.42	0.15	0.07	0.0	287.55
Beone Medicines Ltd	NA	NA	NA	2.29	-0.05	-0.01	NA	34.32
Vertex Pharmaceuticals Incorporated	27.64	27.64	0.58	18.06	0.23	0.13	NA	67.02
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	3.92	-2.58	-0.03	NA	1.91

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Clearside Biomedical Inc	Buy	$31.6M	-92.88%	133.0	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$62.5B	-2.51%	14.86	31.37%
Beone Medicines Ltd	NA	$38.3B	26.72%	NA	-3.89%
Vertex Pharmaceuticals Incorporated	Buy	$99.7B	43.36%	27.64	31.86%
Alnylam Pharmaceuticals, Inc.	Buy	$58.2B	243.29%	NA	-12.96%

About Clearside Biomedical Inc

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide injectable suspension for the treatment of macular edema associated with uveitis. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which has completed Phase 2 clinical trial to treat wet AMD. The company has a collaboration with bausch + lomb ireland limited, Arctic Vision (Hong Kong) Limited, REGENXBIO, Inc., BioCryst Pharmaceuticals, Inc., and Aura Biosciences, Inc. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.

Organization	Clearside Biomedical
Employees	32
CEO	Mr. Charles A. Deignan
Industry	Health Technology

Key Management of Clearside Biomedical Inc

Name	Title
Mr. Charles A. Deignan	Principal Financial Officer & Principal Accounting Officer
Ms. Jenny R. Kobin	Head of Investor Relations
Mr. Rick McElheny	Senior Vice President of Corporate Development & Alliance Management
Mr. Rafael V. Andino	Senior Vice President of Engineering & Manufacturing

Important FAQs about investing in CLSD Stock from India :

What is Clearside Biomedical share price today?

Clearside Biomedical share price today is $0.41 as on August 28, 2025 at 12:35 am IST. Clearside Biomedical share today touched a day high of $0.41 and a low of $0.40.

What is the 52 week high and 52 week low for Clearside Biomedical share?

Clearside Biomedical share touched a 52 week high of $1.65 and a 52 week low of $0.29. Clearside Biomedical stock price today i.e. August 28, 2025 at 12:35 am IST is trending at $0.41, lower by 75.15% versus the 52 week high.

How to invest in Clearside Biomedical Stock (CLSD) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Clearside Biomedical on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Clearside Biomedical Shares that will get you 3.6585 shares as per Clearside Biomedical share price of $0.41 per share as on August 28, 2025 at 12:35 am IST.

What is the minimum amount required to buy Clearside Biomedical Stock (CLSD) from India?

Indian investors can start investing in Clearside Biomedical (CLSD) shares with as little as ₹87.86 or $1 (as of August 27, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹878.60 in Clearside Biomedical stock (as per the Rupee-Dollar exchange rate as on August 27, 2025). Based on Clearside Biomedical share’s latest price of $0.41 as on August 28, 2025 at 12:35 am IST, you will get 24.3902 shares of Clearside Biomedical. Learn more about fractional shares .

What are the returns that Clearside Biomedical has given to Indian investors in the last 5 years?

Clearside Biomedical stock has given -92.88% share price returns and 18.89% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?